The landscape of oncology has undergone a remarkable transformation over the past two decades, driven by groundbreaking research, technological innovation, and a more nuanced understanding of cancer biology.
Ebola surges past 8,000 cases in the Democratic Republic of Congo, with nearly 4,000 deaths reported in the country’s deadliest outbreak.
Digital tools and artificial intelligence could accelerate Ayush’s growth, helping India build a stronger pathway toward the USD 318 billion goal by 2047.
PABS vaccine access is gaining importance as India seeks fair access to vaccines, therapeutics and technologies while strengthening pharma manufacturing capacity.
Regulatory clearances today put Zydus and Lilly in focus, while RPG Life Sciences restructures its API operations for greater efficiency.
This week’s GLP-1 battle intensifies as Novo slips, Roche climbs, and Lilly expands with major obesity and diabetes advances.
Regulatory Check Today shows the FDA backing two oral treatments while maintaining strict evidence standards for accelerated approval.
Sanofi reaffirms its India pharma bet with a 1,068 crore stake purchase, strengthening its local presence through an internal ownership shift.
AI drug discovery is gaining ground in India's pharmaceutical R&D landscape, with Rasayan Labs and ICT Mumbai bringing computational chemistry, molecular design and synthesis planning into a unified drug-discovery workflow.
Roche bets USD 2 billion on oral heart and metabolic pills through a discovery collaboration with Atavistik Bio targeting chronic diseases.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
